1. Parkinsonism treated with 3-0-methyldopa;CALNE, D.B.; REID, J.L.; VAKIL, S.D.;Clinical Pharmacology and Therapeutics,1973
2. False rise in serum uric acid after L-dopa;CAWEIN, M.J.; HEWINS, J.;New England Journal of Medicine,1969
3. Therapeutique substitutive des syndromes de parkinson;GAUTHIER, G.; AJURIAGUERRA, D.E.; J., G.E.I.S.S.B.U.H.L.E.R.; F., S.I.M.O.N.A.; B., C.O.N.S.T.A.N.T.I.N.I.D.I.S.; J., Y.A.N.N.I.O.T.I.S.; G., K.R.A.S.S.O.I.E.V.I.T.C.H.; M., E.I.S.N.R.I.N.G.; J., J.; TiSSOT, R.;Presse Medicale,1971
4. Gout while receiving levodopa for parkinsonism;HONDA, H.; GINDIN, R.A.;Journal of the American Medical Association,1972
5. Plasma 3-0-methyldopa in L-dopa therapy of Parkinson's disease;MUENTER, M.D.; SHARPLESS, N.S.; TYCE, G.M.;Mayo Clinic Proceedings,1972